Vladimir Vexler's most recent trade in Coherus Biosciences Inc was a trade of 16,278 Common Stock done at an average price of $6.8 . Disclosure was reported to the exchange on March 31, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Coherus Biosciences Inc | Vladimir Vexler | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.84 per share. | 31 Mar 2023 | 16,278 | 116,361 (0%) | 0% | 6.8 | 111,342 | Common Stock |
| Coherus Biosciences Inc | Vladimir Vexler | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 40,000 | 131,323 (0%) | 0% | 0 | Common Stock | |
| Coherus Biosciences Inc | Vladimir Vexler | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.85 per share. | 10 Jan 2023 | 3,602 | 94,925 (0%) | 0% | 9.9 | 35,480 | Common Stock |
| Coherus Biosciences Inc | Vladimir Vexler | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.26 per share. | 10 Jan 2023 | 3,602 | 91,323 (0%) | 0% | 10.3 | 36,957 | Common Stock |
| Coherus Biosciences Inc | Vladimir Vexler | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | Vladimir Vexler | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.87 per share. | 04 Jan 2023 | 5,437 | 98,527 (0%) | 0% | 9.9 | 53,663 | Common Stock |
| Coherus Biosciences Inc | Vladimir Vexler | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.85 per share. | 01 Apr 2022 | 3,458 | 103,963 (0%) | 0% | 12.8 | 44,435 | Common Stock |
| Coherus Biosciences Inc | Vladimir Vexler | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.30 per share. | 10 Jan 2022 | 4,150 | 111,004 (0%) | 0% | 14.3 | 59,345 | Common Stock |
| Coherus Biosciences Inc | Vladimir Vexler | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.36 per share. | 10 Jan 2022 | 3,583 | 107,421 (0%) | 0% | 14.4 | 51,452 | Common Stock |
| Coherus Biosciences Inc | Vladimir Vexler | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | Vladimir Vexler | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 40,000 | 115,154 (0%) | 0% | 0 | Common Stock | |
| Coherus Biosciences Inc | Vladimir Vexler | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2021 | 20,000 | 73,386 (0%) | 0% | 0 | Common Stock | |
| Coherus Biosciences Inc | Vladimir Vexler | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 16.25 per share. | 09 Mar 2021 | 114,240 | 53,386 (0%) | 0% | 16.2 | 1,856,263 | Common Stock |
| Coherus Biosciences Inc | Vladimir Vexler | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.05 per share. | 09 Mar 2021 | 57,812 | 167,626 (0%) | 0% | 10.1 | 581,011 | Common Stock |
| Coherus Biosciences Inc | Vladimir Vexler | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2021 | 57,812 | 17,188 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | Vladimir Vexler | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.08 per share. | 09 Mar 2021 | 24,356 | 89,502 (0%) | 0% | 2.1 | 50,753 | Common Stock |
| Coherus Biosciences Inc | Vladimir Vexler | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2021 | 24,356 | 0 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | Vladimir Vexler | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.30 per share. | 09 Mar 2021 | 20,312 | 109,814 (0%) | 0% | 9.3 | 188,902 | Common Stock |
| Coherus Biosciences Inc | Vladimir Vexler | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2021 | 20,312 | 4,688 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | Vladimir Vexler | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | Vladimir Vexler | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2021 | 62,500 | 62,500 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | Vladimir Vexler | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2021 | 31,250 | 65,146 (0%) | 0% | 0 | Common Stock | |
| Coherus Biosciences Inc | Vladimir Vexler | Chief Scientific Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.18 per share. | 10 Jan 2021 | 4,080 | 33,896 (0%) | 0% | 18.2 | 74,174 | Common Stock |
| Coherus Biosciences Inc | Vladimir Vexler | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 18.24 per share. | 09 Dec 2020 | 49,512 | 36,673 (0%) | 0% | 18.2 | 903,084 | Common Stock |
| Coherus Biosciences Inc | Vladimir Vexler | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2020 | 30,000 | 41,982 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | Vladimir Vexler | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.08 per share. | 09 Dec 2020 | 30,000 | 86,185 (0%) | 0% | 2.1 | 62,514 | Common Stock |
| Coherus Biosciences Inc | Vladimir Vexler | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 18.05 per share. | 09 Dec 2020 | 17,626 | 36,673 (0%) | 0% | 18.0 | 318,066 | Common Stock |
| Coherus Biosciences Inc | Vladimir Vexler | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.08 per share. | 09 Dec 2020 | 17,626 | 54,299 (0%) | 0% | 2.1 | 36,729 | Common Stock |
| Coherus Biosciences Inc | Vladimir Vexler | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2020 | 17,626 | 24,356 | - | - | Stock Option (Right to Buy) |